CVS Health Corporation (NYSE:PVH) shares closed slightly higher during Wednesday’s session.
On May 30, JPMorgan analyst Lisa Gill maintained CVS Health with an Overweight. She also lowered the price target from $101 to $86. Baird analyst Michael Ha initiated coverage on CVS Health with a Neutral rating and announced a price target of $61.
On May 1, CVS Health reported first-quarter sales of $88.4 billion, up 3.7% year over year. It missed the consensus of $89.21 billion. The company also lowered its 2024 adjusted EPS guidance to at least $7.00 from at least $8.30 versus consensus of $8.27.
With the recent buzz around CVS Health, some investors may be eyeing potential gains from the company’s dividends. CVS Health currently has a dividend yield of 4.38%. That’s a quarterly dividend amount …